Home » Newsletters » BioWorld Science

BioWorld Science

April 10, 2002

View Archived Issues

MelTec and MyoContract collaborate on Duchenne dystrophy

Selfadministration of new Endostatin formulation in clinical trials

Results of Xanelim pharmacokinetic comparability study

Novel aldose reductase inhibitor for diabetic neuropathy characterized at ACS meeting

Taiho presents novel anticancer compounds that induce p300 gene expression

Synthesis and SAR for new series of chymase inhibitors reported this week in Orlando

Nonsteroidal LXR agonist with good potency and selectivity discovered at GSK

AGI-1067: discovery discussed, structure revealed at ACS meeting

Cdc25 inhibitor described at AACR meeting as warranting further evaluation as an anticancer agent

IDN-5390 as a novel taxane suitable for protracted administration

ACS news: nonsteroidal GR-selective antagonists discovered by Abbott and Karo Bio

Inhibitors of VEGF useful for cancer and rheumatoid arthritis described in AstraZeneca patents

Cyclacel and University of Edinburgh enter scientific collaboration

Colostrinin shows trend for efficacy in Alzheimer's disease

CeNeS offers summary of 2001 highlights

FDA approves new indication for argatroban

Abbott seeks U.S. and E.U. approval for D2E7 in rheumatoid arthritis

MVA-Muc1-IL-2 enters new phase II trial in prostate cancer

Priority review granted for pediatric labeling of Prevacid

Berna Biotech and Iomai collaborate to develop transdermal patch vaccines

InterMune licenses pirfenidone for fibrotic diseases

U. of Kansas designs new viral protease inhibitors

Complement C5a antagonists in the Mitsubishi Pharma pipeline

Sankyo presents new immunosuppressants in recent patent

Series of macrolide antibiotics reported by Pfizer

New BASF compounds for vitronectin-related disorders

Inhibitors of DPP-IV and potential uses thereof described in recent patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...